Skip to Content

WATSON 3211 (Rivastigmine 6 mg)

Pill with imprint WATSON 3211 is Brown & Orange, Capsule-shape and has been identified as Rivastigmine tartrate 6 mg. It is supplied by Watson Pharmaceuticals.

Rivastigmine is used in the treatment of alzheimer's disease; lewy body dementia; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 3211

Rivastigmine tartrate 6 mg WATSON 3211
Rivastigmine tartrate 6 mg WATSON 3211
Rivastigmine tartrate 6 mg WATSON 3211

Rivastigmine tartrate

6 mg
Brown & Orange
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
titanium dioxide
ferric oxide yellow
ferric oxide red
ferrosoferric oxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
63739-0579 McKesson Packaging Services

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.